Target intelligence / Profile preview

Zinc finger protein 292 (ZNF292)

Target
ZNF292
Molecular classification
Transcription factor, Zinc finger protein (specifically C2H2 type), Nuclear protein
01

Overview

Zinc finger protein 292 (ZNF292) is a large, highly conserved transcription factor in the C2H2 zinc finger family, containing 16 zinc finger domains and expressed primarily in the nucleus. It is critical for normal neurodevelopment—mutations in the ZNF292 gene are associated with neurodevelopmental disorders such as intellectual disability, autism spectrum disorder, and ADHD. As a transcription factor, ZNF292 binds DNA, with notable activity at the growth hormone (GH1) gene promoter in cooperation with other factors, and enhances growth hormone gene expression in somatotrophs. It functions as a tumor suppressor, with loss-of-function mutations linked to colorectal, gastric, and other cancers. Emerging evidence indicates ZNF292 and its circular RNA derivative (circZNF292) also play roles in cell stress responses, cataract formation, and cardiovascular pathology. Its only well-established drug-related activity is in gene-level studies; ZNF292 is not currently a recognized therapeutic drug target, nor are there approved drugs that target it directly.

Other names
ZNF292KIAA0530ZFP292bA393I2.3Zn-15Zn-16MRD63MRD64Nbla00365ZN-1616 zinc-finger domain proteinputative protein product of Nbla00365zinc finger protein 292
02

Biological functions

DNA bindingTranscriptional regulationCell type maintenanceGrowth hormone gene expression (enhancer)RNA and protein interactionsNeurodevelopment
03

Disease associations

Neurodevelopmental disorder (including intellectual disability, autism spectrum disorder, ADHD)Cancer (tumor suppressor in colorectal cancer, gastric cancer, leukemia)Age-related cataract (via circZNF292)Cardiovascular stress (via circZNF292 in response to hypoxia and sleep apnea)

Beyond the preview

Go deeper on Zinc finger protein 292 (ZNF292).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zinc finger protein 292 (ZNF292).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call